AVNS
Avanos Medical Stock Analysis
AI Rating
- Quality6/10
- Growth↓ 0/10
- Momentum↑ 7/10
AVNS Growth
- Revenue Y/Y↓ 2.70%
- EPS Y/Y↓ -3097.06%
- FCF Y/Y↑ 115.57%
AVNS Profitability
- Gross margin ↑ 52.30%
- EPS margin↓ -67.00%
- ROIC↓ -102.80%
AVNS Risk
- Debt / Equity↓ 0.2
- Debt / FCF↓ 0.8
- Interest coverage↓ -55.1
Avanos Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.